Synthesis, In Silico, and Biological Evaluation of Non‐Hydroxamate Benzoic Acid–Based Derivatives as Potential Histone Deacetylase Inhibitors (HDACi)
Chemistry & Biodiversity · 2025-12 · 22 (12)
DOI: 10.1002/cbdv.202501492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 02.09.2025. Verfasst von Nedaa A Abd Al Rahim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Histone Deacetylases, Antineoplastic Agents, Benzoates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hashemite University.
Abstract (Originalsprache)
Unregulated epigenetic modifications, including histone acetylation/deacetylation mediated by histone acetyltransferases (HATs) and histone deacetylases (HDACs), contribute to cancer progression. HDACs, often overexpressed in cancer, downregulate tumor suppressor genes, making them crucial targets for treatment. This work aimed to develop non‐hydroxamate benzoic acid–based HDAC inhibitors (HDACi) with comparable effect to the currently four FDA‐approved HDACi, which are known for their poor solubility, poor distribution, and significant side effects. All compounds were structurally verified using FTIR, 1 HNMR, 13 CNMR, and mass spectrometry. In silico analysis showed that compound A3bn (3‐chloro‐4‐((2‐(2‐(4‐hydroxybenzylidene) hydrazinyl)‐2‐oxoethyl)amino)benzoic acid) has strong binding affinity towards HDAC2, HDAC6, and HDAC8 and exhibits molecular similarity to trichostatin and SAHA (HDACi). A3bn achieved IC 50 values comparable to SAHA against MCF‐7 (20.3 vs. 39.2 µM) and K562 (42.0 vs. 36.1 µM) cancer cells. Western blot analysis confirmed that A3bn inhibited H3 and H4 deacetylation. Additionally, A3bn induced the extrinsic apoptotic pathway via caspase 8 activation, leading to cell death. Its enhanced activity across HDAC isoforms may result from its hydrophilic linker, facilitating zinc coordination. In conclusion, A3bn demonstrated efficacy similar to FDA‐approved HDACi and represents a promising candidate for further optimization. Future studies will focus on structural modifications to enhance potency and selectivity at lower concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
- Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan.
- Department of Biochemistry and Molecular Biology, College of Natural Sciences, Colorado State University, Fort Collins, Colorado, USA.
- Department of Medical Laboratory, Faculty of Allied Sciences, Zarqa University, Zarqa, Jordan.
- Department of Basic Dental Sciences, Faculty of Dentistry, The Hashemite University, Zarqa, Jordan.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
ORCID-Profile: Ammar A Razzak Mahmood, Lubna H Tahtamouni
Förderung
- Hashemite University
Zitieren
APA
Al Rahim, N. A. A., Mahmood, A. A. R., Tahtamouni, L. H., Bawadi, R. M., Almasri, A. Y., Hamad, M. A., Hussein, N. A., Yasin, S. R., & Saleh, A. M. (2025). Synthesis, In Silico, and Biological Evaluation of Non‐Hydroxamate Benzoic Acid–Based Derivatives as Potential Histone Deacetylase Inhibitors (HDACi). Chemistry & Biodiversity, 22(12). https://doi.org/10.1002/cbdv.202501492
Vancouver
Al Rahim NAA, Mahmood AAR, Tahtamouni LH, Bawadi RM, Almasri AY, Hamad MA, et al. Synthesis, In Silico, and Biological Evaluation of Non‐Hydroxamate Benzoic Acid–Based Derivatives as Potential Histone Deacetylase Inhibitors (HDACi). Chemistry & Biodiversity. 2025;22(12). doi:10.1002/cbdv.202501492
BibTeX
@article{AlRahim2025,
author = {Al Rahim, Nedaa A Abd and Mahmood, Ammar A Razzak and Tahtamouni, Lubna H and Bawadi, Randa M and Almasri, Ayah Y and Hamad, Marya A and Hussein, Nour A and Yasin, Salem R and Saleh, Abdulrahman M},
title = {Synthesis, In Silico, and Biological Evaluation of Non‐Hydroxamate Benzoic Acid–Based Derivatives as Potential Histone Deacetylase Inhibitors (HDACi)},
journal = {Chemistry & Biodiversity},
year = {2025},
volume = {22},
number = {12},
doi = {10.1002/cbdv.202501492}
}
EUVIMED